Risk Factors Update Summary
- Accumulated deficit increased from approximately $367 million to $419 million by the year ended December 31, 2023.
- Net losses increased from $52.1 million in 2022 to $65.4 million in 2023.
- Medicare reimbursement for diagnostic test revenue increased from 18% in 2022 to 37% in 2023.
- Full and part-time employees decreased from approximately 245 to 217 by the year ended December 31, 2023.
- Quarterly installments for Milestone Payments increased from $2.0 million to $3.0 million beginning in July 2023.
- Quarterly installments for Milestone Payments increased to one installment of $5.0 million in April 2024.
- Quarterly installments for Milestone Payments increased to one installment of approximately $8.4 million.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=1439725&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.